Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONVINCE low-dose colchicine after non-cardioembolic stroke or transient ischemic attack
2015-004505-16Phase 3Completed
- Sponsor
- University College Dublin
- Start
- Jun 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of colchicine in ischemic stroke and transient ischaemic attack (TIA) (2 arms), sponsored by University College Dublin. Primary endpoint: Primary efficacy outcome. Started Jun 2016; status: completed.
02
Drugs
colchicine
03
Conditions
ischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on 2015-004505-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004505-16.